(R)-3-((tert-Butoxycarbonyl)amino)-3-(4-ethylphenyl)propanoic acid
95%
- Product Code: 231162
CAS:
1228568-66-8
Molecular Weight: | 293.35 g./mol | Molecular Formula: | C₁₆H₂₃NO₄ |
---|---|---|---|
EC Number: | MDL Number: | MFCD06227904 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, Sealed |
Product Description:
Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its stereochemistry allows for selective interactions in drug design, enhancing potency and reducing side effects. Commonly employed in peptide mimetics and structure-activity relationship studies due to the protected amine and carboxylic acid functionalities, enabling stepwise coupling in solid-phase or solution-phase synthesis.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | €424.68 |
+
-
|
0.250 | 10-20 days | €574.26 |
+
-
|
1.000 | 10-20 days | €1,853.06 |
+
-
|
(R)-3-((tert-Butoxycarbonyl)amino)-3-(4-ethylphenyl)propanoic acid
Used as a chiral intermediate in the synthesis of pharmaceutical compounds, particularly in the development of protease inhibitors and other biologically active molecules. Its stereochemistry allows for selective interactions in drug design, enhancing potency and reducing side effects. Commonly employed in peptide mimetics and structure-activity relationship studies due to the protected amine and carboxylic acid functionalities, enabling stepwise coupling in solid-phase or solution-phase synthesis.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :